Withdrawal Test in HBeAg-negative Patients

被引：0
|
作者：
Berg, T. [1 ]
机构：
[1] Univ Klinikum Leipzig, Klin & Poliklin Gastroenterol & Rheumatol, Liebigstr 20, D-04103 Leipzig, Germany
来源：
GASTROENTEROLOGE | 2018年 / 13卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：406 / 406
页数：1
相关论文
共 50 条
  • [41] The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis
    Kilic, Z. Mesut Yalin
    Kuran, Sedef
    Akdogan, Meral
    Cicek, Bahattin
    Oguz, Dilek
    Odemis, Bulent
    Sasmaz, Nurgul
    ADVANCES IN THERAPY, 2008, 25 (03) : 190 - 200
  • [42] Antiviral therapy leads to histological improvement in HBeAg-negative chronic hepatitis B patients
    Basyigit, Sebahat
    Sapmaz, Ferdane
    Yeniova, Abdullah O.
    ANNALS OF GASTROENTEROLOGY, 2015, 28 (04): : 506 - +
  • [43] MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients
    Chen, Xiaoman
    Zhou, Jing
    Wu, Lili
    Zhu, Xiang
    Deng, Hong
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 673 - 683
  • [44] Comparative study on the clinical characteristics of HBV/HCV co-infection patients with HBeAg-positive and HBeAg-negative
    Zhang, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 146 - 146
  • [45] What Should Be the Endpoints of Oral Therapy in HBeAg-positive Versus HBeAg-negative Patients with Chronic Hepatitis B
    Stephanos J. Hadziyannis
    Dimitrios Vassilopoulos
    Current Hepatitis Reports, 2012, 11 (2) : 65 - 69
  • [46] Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemia
    Bozkaya, H
    Yurdaydin, C
    Idilman, R
    Tüzün, A
    Cinar, K
    Erkan, Ö
    Bozdayi, AM
    Erden, E
    Uzun, Y
    Cetinkaya, H
    Uzunalimoglu, Ö
    ANTIVIRAL THERAPY, 2005, 10 (02) : 319 - 325
  • [47] The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients
    Chien-Wei Peng
    Wen-Juei Jeng
    Hepatology International, 2021, 15 : 527 - 528
  • [48] The present situation and prospect of research on HBeAg-negative mouse model
    Liu, Yang
    Zhang, Huatang
    Lai, Guoqi
    CHINESE SCIENCE BULLETIN-CHINESE, 2019, 64 (30): : 3077 - 3083
  • [49] Treatment of HBeAg-negative chronic hepatitis B with pegylated interferon
    Lampertico, Pietro
    Vigano, Mauro
    Colombo, Massimo
    LIVER INTERNATIONAL, 2011, 31 : 90 - 94
  • [50] Antiviral agents in HBeAg-negative liver disease0
    Valerie Byrnes
    Nezam H. Afdhal
    Current Hepatitis Reports, 2005, 4 (1) : 21 - 26
12345